BHST (BioHarvest Sciences) Total Equity: $23.02 Mil (As of Mar. 2026)


BHST BioHarvest Sciences Inc BHST
63 GF Score
Price $2.77
GF Value $8.57
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BioHarvest Sciences Total Equity?

BioHarvest Sciences BHST -1.42% 63 Total Equity is $23.02 Mil as of Mar. 2026. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.57 (Possible Value Trap). The stock has 4 warning signs investors should review.

BioHarvest Sciences's total equity for the quarter that ended in Mar. 2026 was $23.02 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

BioHarvest Sciences Total Equity Historical Data

* Premium members only.

The historical data trend for BioHarvest Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioHarvest Sciences Total Equity Chart

BioHarvest Sciences Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.86 -5.93 -14.85 1.33 25.45

BioHarvest Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 -4.22 7.74 25.45 23.02
BHST
63GF Score
BioHarvest Sciences Inc BHST
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioHarvest Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

BioHarvest Sciences's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=47.665-22.217
=25.45

BioHarvest Sciences's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=45.558-22.535
=23.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $23.02 Mil mean?
BioHarvest Sciences (BHST) has a Total Equity of $23.02 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for BioHarvest Sciences and its competitors.
Is BioHarvest Sciences' Total Equity too high?
BioHarvest Sciences' current Total Equity is $23.02 Mil. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' Total Equity compare to GWLL and CLNN?
BioHarvest Sciences' Total Equity of $23.02 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Consumer Packaged Goods company?
A good Total Equity depends on the Consumer Packaged Goods industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for BioHarvest Sciences and its competitors. BioHarvest Sciences's current Total Equity is $23.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.57, compared to a current price of $2.77 — trading 67.7% below its estimated fair value. The current Total Equity is $23.02 Mil. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current Total Equity is $23.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioHarvest Sciences (BHST) Overvalued in 2026?

Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued. The current stock price of $2.77 is trading 67.7% below its estimated GF Value™ of $8.57. GuruFocus considers BioHarvest Sciences to be Possible Value Trap.

Key valuation signals for BHST:

  • Total Equity: $23.02 Mil
  • GF Value™: $8.57 vs. price of $2.77 (67.7% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioHarvest Sciences Business Description

Other Exchanges 8MV0:Germany
Address 1140-625 Howe Street, Vancouver, BC, CAN, V6C 2T6
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score

Get the complete analysis for BHST

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.77
Price
$8.57
GF Value